Forum for Science, Industry and Business

Virtual Screening Lab Zeroes in on New Drugs

17.03.2004

Researchers at Rensselaer Polytechnic Institute (RPI) have come up with computational tools that serve as a virtual screening lab to help chemists weed through millions of possible drug candidates even before they dirty their first test tube.

Chemist Curt Breneman, mathematician Kristin Bennett, and computer scientist Mark Embrechts developed faster and more accurate techniques for describing molecules and combined them with next-generation neural networks and learning methods as part of the Drug Discovery and Semi-Supervised Learning (DDASSL) project.

Funded by a $1.2 million National Science Foundation Knowledge and Distributed Intelligence award, the DDASSL (pronounced "dazzle") project has spawned a number of descendants. Today, 10 research projects on the RPI campus, ranging from the life sciences to materials science to cybersecurity, can trace their origins in part to DDASSL (http://www.drugmining.com/).

In addition, Concurrent Pharmaceuticals, based in suburban Philadelphia, is evaluating the DDASSL techniques in a real-world environment. According to Jean-Pierre Wery, Concurrents vice president of computational drug discovery, the information used by DDASSL is different from what has been used traditionally. "These tools are consistent with Concurrents efforts to change the way we think about the drug discovery process," Wery said.

When starting to develop a new drug to attack a particular biological target, a pharmaceutical chemist is confronted with the accumulated knowledge stored in vast public and corporate databases on tens of millions of potential drug molecules and their effects.

DDASSL techniques and a relatively inexpensive Linux cluster provide a fast and accurate tool for pinpointing the likeliest candidates from these databases. DDASSL can screen 10 million molecules per day for their potential drug interaction with a model of the biological target molecule.

By comparison, the best virtual screening techniques prior to DDASSL would use less accurate molecule descriptors and still examine less than a million molecules in a day. Actual laboratory tests top out at several hundred or thousand per day even with the latest high-throughput equipment.

"DDASSL tools are also an easy way to take an idea and run it past a model," Breneman said. "Chemists can test their wild ideas quickly and without the expense of a lab test."

Die letzten 5 Focus-News des innovations-reports im Überblick:

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...